Nucleai
@nucleai_ai
Followers
231
Following
236
Media
503
Statuses
681
Revolutionizing precision medicine through AI-powered spatial biology. Improving drug development, clinical decisions, and patient outcomes.
Israel / USA
Joined October 2020
Results from our collaboration with @BioTechne and @lunaphore based on the #SECOMBIT trial, will be presented at #SITC25, showing how AI-powered multimodal analysis and high-plex #spatialbiology can identify predictive #biomarkers in #melanoma. Read more https://t.co/q0maXdvJk4
0
0
0
AI spatial insights are helping refine biomarker and patient selection strategies in breast cancer. Explore our latest case studies and poster highlights. #BreastCancerAwarenessMonth
https://t.co/Gq9a46gTBC
0
0
0
Innovation in healthcare doesn’t move at the speed of computation - it moves at the speed of verification. Read our CEO, @avi_ve's latest post to learn why verification speed is critical to #innovation in #healthtech - and what we can do to accelerate it. https://t.co/T4suRHUQfm
0
0
0
The countdown is on! We’re gearing up for #WorldADC25. Visit us at Booth #32 to discover how #AIPathology and #SpatialBiomarker Solutions can advance ADC #drugdevelopment and enhance your #biomarker strategy. 📅 Book a meeting: https://t.co/ZJx9ssCkVQ
0
0
0
#HLTHUSA starts this Sunday and we’re bringing AI-powered spatial biomarkers and diagnostics to the forefront to improve clinical decision-making and patient outcomes. Let’s meet in Las Vegas. Book a meeting: https://t.co/a5CIWqawLH
0
1
1
Targeted therapies have transformed #BreastCancer care, yet not all biomarker-positive patients respond to treatment. Nucleai’s AI spatial solutions provide deeper insights into tumor biology to support more personalized and effective treatment decisions in breast cancer.
0
0
0
Can spatial biology reveal why some patients don’t respond to #immunotherapy? Join Dr. Ettai Markovits as he shares new evidence of a predictive metabolic signature linked to immunotherapy resistance. 🎥 Watch the full webinar on demand: https://t.co/8feZfJEqY5
0
0
0
Conference season is in full swing — next stop: #WorldADC. Don’t miss Dr. Ken Bloom on how AI-powered Quantitative Continuous Scoring (#QCS) and Spatial Proximity Analysis are transforming #ADC #biomarker development. 🔗 https://t.co/Q8KlSuWQNH
#SpatialBiomarkers #AIpathology
0
0
0
Missed us at Pathology Visions 2025? You can now download our poster showcasing new data from the Analysis Studio — turning complex computational outputs into explainable insights that accelerate biomarker discovery and advance personalized therapies. 📄 https://t.co/HhtqBswvcc
0
0
0
Honored to be named one of the Top 10 #SpatialBiology Companies of 2025 by @GENbio for the third year in a row! This year, we launched our first-of-its-kind deep learning model and OD-based scoring to advance #BiomarkerDiscovery for #ADCs & IO. https://t.co/fYHDNp8UO1
0
0
1
0
0
0
Pathology Visions 2025 is almost here. Dr. Ken Bloom will present new data from our Analysis Studio — bridging complex computational outputs with scientific understanding through spatial proximity scoring, quantitative continuous scoring, and more. https://t.co/kFNgW6OMLk
1
0
0
We’re excited to bring AI-powered #spatialbiomarkers and diagnostics to the forefront, improving clinical decision-making and transforming patient outcomes. Our CEO & Co-Founder, @avi_ve, will be in Las Vegas for #HLTH2025. Going to HLTH? Let’s connect! https://t.co/EkasX90jla
0
0
0
A new Cancer Cell study demonstrates how spatial biomarkers + AI could predict efficacy of HER2-targeted ADCs. In our blog, we share how Nucleai’s high-res, OD-based IHC quantification & spatial analysis enable smarter ADC research. 👉 https://t.co/f2W9OQNDnS
1
0
0
🚀 Excited to kick off World CB & CDx tomorrow in Boston! We’re looking forward to connecting with you and sharing how AI spatial proteomics can support ADC programs and help advance next-generation therapeutics. 📍 Booth #11 | 👉 Book a meeting: https://t.co/cpcmP7kYm3
0
0
1
Wishing everyone celebrating a Shanah Tovah — a sweet and meaningful New Year. Thank you to our team, partners, and clients for your continued trust and support. 🍎🍯 שנה טובה ומתוקה!
0
0
0
⏰Tomorrow at 11 AM ET. Don’t miss #NucleaiAcademy on IO Resistance & #Biomarker Strategies 🔗 Register now: https://t.co/kLIhU5ofTw (Can’t join live? Registrants get the recording.)
0
0
0
Join us next week at #NucleaiAcademy to learn how advanced spatial and AI-driven approaches combined with multiplex imaging (mIF) can accelerate #biomarkerdiscovery for #immunotherapy response. RSVP 👉 https://t.co/WVOV9EDckk
0
0
0
🔬Join us at World CB & CDx 2025 to learn how spatial biomarkers are shaping ADC development. 👉 Book a meeting: https://t.co/GQA4krlkrs
#WorldCDx25 #WorldCDx #WorldCDx2025 #CDx #ADC #spatialbiomarkers #aipathology #digitalpathology #biomarkers
0
0
0